Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ 110,694 $ (13,962)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 576,342 724,462
Amortization of right-of-use assets 59,058 57,182
Amortization of debt issuance costs and debt discount 377,261 369,741
Bad debt expense (recovery) 37,855 (15,831)
Deferred income tax (15,294) (168,681)
Share-based compensation 244,923 310,002
Changes in operating assets and liabilities:    
Accounts receivable (2,263,475) 14,836
Income tax receivable (20,869) 793,522
Prepaid expenses and other current assets 290,566 34,989
Other assets (86,025) 27,870
Accounts payable 1,716,315 114,236
Accrued expenses (1,603,191) (784,082)
Revenue contract liability (15,960) 68,750
Operating lease liabilities (60,418) (56,088)
Net cash (used in) provided by operating activities (652,218) 1,476,946
Cash flows from investing activities:    
Investment in internally developed software (283,049) (59,616)
Acquisition of property and equipment (6,908) (6,131)
Acquisition of assemblies in process assets (13,937) (110,710)
Net cash used in investing activities (303,894) (176,457)
Cash flows from financing activities:    
Payments of debt issuance costs (6,829)  
Proceeds from stock option exercises   195,456
Principal payments on long-term debt (899,410) (315,936)
Net cash used in financing activities (906,239) (120,480)
Effect of exchange rate changes on cash 11,299 3,379
Net increase in cash and cash equivalents (1,851,052) 1,183,388
Cash and cash equivalents – beginning of period 18,237,513 16,058,714
Cash and cash equivalents – end of period 16,386,461 17,242,102
Supplemental cash flow information:    
Cash paid for interest 1,823,227 $ 1,358,531
Cash paid for income taxes $ 18,350